UONDDL
NBIX icon

University of Notre Dame du Lac’s Neurocrine Biosciences NBIX Stock Holding History

University of Notre Dame du Lac’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,527
Closed -$911K – 53
2020
Q1 		$911K Buy
10,527
+1,829
+21% +$179K 0.28% 45
2019
Q4 		$935K Sell
8,698
-685
-7% -$71.7K 0.3% 48
2019
Q3 		$846K Sell
9,383
-36,907
-80% -$3.45M 0.25% 45
2019
Q2 		$3.91M Buy
+46,290
New +$3.8M 0.89% 43

Other funds holding NBIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

University of Notre Dame du Lac's NBIX Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Neurocrine Biosciences (NBIX) in Q2 2020, closing a stake of 10,527 shares — an estimated $911K sold.

University of Notre Dame du Lac first reported a position in NBIX in Q2 2019 and held it in 4 quarters. The position peaked at $3.91M in Q2 2019. 419 funds tracked by Wall St. Rank hold NBIX as of Q2 2020.

  • University of Notre Dame du Lac reported no remaining Neurocrine Biosciences position as of Q2 2020 after selling out during the quarter.
  • University of Notre Dame du Lac sold 10,527 Neurocrine Biosciences shares in Q2 2020, an estimated $911K.
  • University of Notre Dame du Lac first reported a position in Neurocrine Biosciences in Q2 2019 and held it in 4 quarters.
  • University of Notre Dame du Lac's Neurocrine Biosciences position peaked at $3.91M in Q2 2019.
  • 419 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.